An Assessment of Chronic Synovial-Based Inflammation and Its Role With Serum Urate Levels.
Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to show that patients with gout suffer from chronic inflammation
of their joints, observable by MRI, even in the absence of symptomatic gouty attacks.
Secondary end-points of this study will include analyzing the effects of uric acid-lowering
therapy (specifically with the FDA approved medication Febuxostat) in a subgroup of patients,
checking for the presence of inflammatory markers to see if there is any correlation with the
proposed chronic inflammation, and evaluating for other characteristic findings of gout on
MRI.